DailyStocks Stock Article Search

https://www.wired.com/story/chatgpt-poem-forever-security-roundup/ Dec 02, 2023 - Plus: A major ransomware crackdown, the arrest of Ukraine’s cybersecurity chief, and a hack-for-hire entrepreneur charged with attempted murder. 0

https://seekingalpha.com/news/4043046-23andme-stock-gains-data-breach-impacts-01-users?source=feed_sector_healthcare Dec 04, 2023 - 23andMe (ME) stock gained ~11% on Monday after announcing that hackers accessed only 0.1% of customer accounts during a recent data breach. Read more here. 0

https://www.rttnews.com/3409421/european-economic-news-preview-eurozone-final-pmi-data-due.aspx?type=alleco Dec 04, 2023 - Final composite Purchasing Managers' survey results are due from the euro area and the UK on Tuesday, headlining a busy day for the European economic news. At 2.45 am ET, France's INSEE is scheduled to issue industrial production data for October. Economists forecast output to grow 0.2 percent on a monthly basis, in contrast to the 0.5 percent decrease in September. 0

https://www.rttnews.com/3409373/australia-gdp-data-due-on-wednesday.aspx?type=alleco Dec 05, 2023 - Australia will on Wednesday release Q3 figures for gross domestic product, highlighting a light day for Asia-Pacific economic activity. 0

https://seekingalpha.com/news/4043552-hackers-accessed-personal-data-for-69m-23andme-users-report?source=feed_sector_healthcare Dec 05, 2023 - 23andMe (ME) has reportedly disclosed that hackers were able to access personal data for around 50% of its users, or 6.9M people, during a data breach last fall. Read more here. 0

https://seekingalpha.com/news/4043544-olema-stock-falls-after-data-lead-asset-breast-cancer?source=feed_sector_healthcare Dec 05, 2023 - Olema Pharmaceuticals (OLMA) announces interim results from a Phase 1b/2 clinical study for its breast cancer drug palazestrant. Read more here. 0

https://seekingalpha.com/news/4044034-jefferies-upgrades-arvinas-to-buy-in-wake-of-positive-arv-471-data?source=feed_sector_healthcare Dec 06, 2023 - Jefferies upgraded Arvinas (ARVN) to buy following positive data for its breast cancer drug ARV-471 in combination with Pfizer's Ibrance. Read more here. 0

https://www.rttnews.com/3410006/european-economic-news-preview-germany-industrial-output-data-due.aspx?type=alleco Dec 06, 2023 - Industrial production from Germany and house prices from the UK are the top economic news due on Thursday. At 2.00 am ET, Destatis is scheduled to issue Germany's industrial production data for October. Output is expected to grow 0.2 percent on month, in contrast to the 1.4 percent fall in September. 0

https://www.rttnews.com/3409686/china-trade-data-on-tap-for-thursday.aspx?type=alleco Dec 06, 2023 - China will on Thursday release November numbers for imports, exports and trade balance, highlighting a modest day for Asia-Pacific economic activity. 0

https://www.rttnews.com/story.aspx?Id=3409889 Dec 06, 2023 - Syros Pharmaceuticals (SYRS) announced Wednesday positive initial data from its ongoing SELECT-AML-1 Phase 2 trial evaluating tamibarotene, in combination with venetoclax and azacitidine in newly diagnosed, unfit patients with acute myeloid leukemia or AML and RARA gene overexpression. 0